TotalMarketCap

Artelo Biosciences

ARTLNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.161 M

$2.12 -6.61%

Close of 6 Nov 2026

As of 6 Nov 2026, Artelo Biosciences (ARTL) has a market capitalization of $1.16M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$12.9M

Loss-making

Shares outstanding

4,595,068

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #493PMGCELAB$1.32M
  2. #494Biodexa PharmaceuticalsBDRX$1.26M
  3. #495Artelo BiosciencesARTL$1.16M
  4. #496Matinas BioPharmaMTNB$1.10M
  5. #497CDT EquityCDT$881.5K

What if Artelo Biosciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$51,548,396

Per share 24,315,281× higher

Bitcoin $1.53T

$2,789,194

Per share 1,315,658× higher

Apple $5.02T

$9,156,663

Per share 4,319,181× higher

Or at a round number

$2.00M$5.00M$10.0M$20.0M

Where these numbers come from

Share counts and financials for Artelo Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.